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ABSTRACT  Treatment  of  infected  L cells  with  10 /~g/ml cytochalasin  B (CB) was  found  to 
promote a rapid relocalization of viral glycoproteins on the cell surface.  Whereas the vesicular 
stomatitis virus G protein and the influenza virus hemagglutinin were uniformly distributed on 
the  surface  of untreated  cells,  in  CB-treated  cells,  they were strikingly  concentrated  at cell 
extremities  in the regions  of clustered  blebs.  Glycoprotein  concentration  at cell extremities 
was  accompanied  by  preferential  maturation  of  virus  particles  from  the  same  sites;  both 
vesicular stomatitis and influenza viruses  budded predominantly from the vicinity of clustered 
blebs.  This  effect  of  CB  was  completely  reversible.  Removal  of  CB  from  the  cell  growth 
medium resulted in a return of viral  glycoproteins to the uniform distribution characteristic of 
untreated cells and to uniform virus budding. The results of this study are interpreted in terms 
of a model that suggests that preferential  budding of viruses  from the regions  of bleb clusters 
is due to the concentration of viral  glycoproteins at these sites. 
The  cytochalasins  have  a  profound  effect  on  the  surface 
morphology of a wide variety of cultured mammalian cells. 
Within minutes after sensitive cells are treated with effective 
doses ofcytochalasin B (CB) ~  or cytochalasin D, the cytoplasm 
contracts  and  blebs  (also  called  blisters,  zeiotic  knobs,  or 
knobby protuberances) appear on the cell surface (l, 6, 8, 14- 
16, 22, 23).  Over the next 30-120 min the blebs aggregate to 
form clusters (also called rosettes, crowns, or bouquets) on 
the upper surface of substrate-adherent cells or at one pole in 
the case of suspension cells (14,  17). Adherent cells may react 
further by acquiring an "arborized" (20,  21,  26)  or macro- 
vacuolated (2,  3) morphology after 12-48  h in the presence 
of the  drug.  The  cellular  response  to  the  cytochalasins  is 
temperature-dependent (14), and it requires an input of met- 
abolic energy (16,  22).  Colchicine does not affect the cyto- 
plasmic contraction or bleb formation promoted by the cy- 
tochalasins,  but  it blocks aggregation of blebs into  clusters 
(17,  27).  All  morphologic  effects of the  cytochalasins  are 
reversible when the drug is withdrawn from the cell growth 
medium (22,  26). 
Sundquist  and his colleagues (27,  28) have demonstrated 
that CB-induced changes in cell surface morphology are ac- 
companied by an equally dramatic relocalization of certain 
cell surface proteins. The case of surface ~2-microglobulin in 
Abbreviations used in this paper:  CB, cytochalasin B; HA, hemag- 
glutinin; MDCK, Madin-Darby canine kidney; VSV, vesicular sto- 
matitis virus. 
Lu 106 (transformed human lung) cells is illustrative. Whereas 
B2-microglobulin is uniformly distributed  on the surface of 
untreated  cells,  it is relocalized into  a  "cap" at the  site of 
clustered blebs in cells treated with  10 #g/ml CB.  The CB- 
induced redistribution of/32-microglobulin is reversible and it 
is inhibited by colchicine. CB is found to promote a similar 
relocalization of H-2 antigens in transformed 3T3 cells (28), 
/32-microglobulin  in HeLa cells,  and measles virus hemaglu- 
tinin in persistently infected Lu 106 cells (27). 
The studies described below have focused on the effect of 
CB on the surface distribution  of viral glycoproteins in  in- 
fected cells. The project was undertaken to test the idea that 
if CB were to restrict the distribution of viral glycoproteins to 
particular areas of the infected cell  membrane (as it does in 
the case of the measles virus hemagglutinin), then virus par- 
ticles should mature only from those glycoprotein-containing 
sites.  Viruses should bud preferentially from membrane re- 
gions containing  their specific envelope glycoproteins. Our 
experimental tests involved infecting L-929 cells with vesicu- 
lar stomatitis virus (VSV) or with influenza virus and treating 
the infected cells with CB. Cells were then examined for the 
surface distribution of virus-specific glycoproteins and for the 
sites of virus maturation. 
MATERIALS  AND  METHODS 
Cell and Virus Growth:  L-929  (mouse)  cells  were propagated  in 
suspension at 37°C in Eagle's minimal essential medium modified for suspen- 
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© The Rockefeller University Press • 0021-9525/85/02/357107  $1.00  35 7 sion cultures (Flow Laboratories, Inc., Rockville,  MD) containing 3% fetal calf 
serum  and  antibiotics  as  previously described  (12).  Experiments involving 
adherent cells were carried out with subconfluent monolayer cultures prepared 
by allowing suspension cells to attach overnight to glass or plastic surfaces in 
Dulbecco's modified  minimal essential medium or in  Eagle's basal medium 
containing 3%  fetal  calf serum and antibiotics.  The cell  reaction to CB was 
comparable on  glass  and  on plastic  surfaces, and  it  did  not depend  on the 
identity of the medium employed. CB (Sigma Chemical Co., St.  Louis, MO) 
was added to cell cultures from a  1 mg/ml stock solution prepared in ethanol. 
Solvent in the absence of drug did not affect  cell morphology or glycoprotein 
localization. 
Stock  cultures  of VSV-lndiana  (Mudd-Summers  strain)  were  grown on 
monolayer cultures of baby hamster kidney-21  cells  as previously described 
(11).  L  cells  were infected  at  a  multiplicity  of infection  of 2  in  cell  growth 
medium  (containing  1.5% rather than  3%  fetal  calf serum). The  virus was 
allowed  to  attach  to  cells  for  1 h  at  room temperature,  and  infection  was 
continued for a total of 6-10 h at 37*. Cultures showing marked cytopathologic 
effects  (such as cell  rounding or detachment  from  the  substrate) were  not 
employed for cytochalasin experiments. The WSN strain of influenza A (the 
gift of Dr. W. Young and Dr. G. Nichols, University of Virginia) was grown 
on Madin-Darby canine kidney (MDCK) cells and employed to infect L cells 
as described above for VSV, 
Light and Electron Microscopy:  L-cell monolayerswere prepared 
for phase-contrast microscopy by growing them in 25 cm  2 plastic tissue culture 
flasks. Flasks of cells were drug-treated as described in the text and photographed 
at various intervals, in a  Leitz Diavert inverted, phase-contrast tissue culture 
microscope (E.  Leitz,  Inc., Rockleigh,  N  J), which was maintained in a warm 
(37*) environment. 
Scanning electron microscopy was carried out with L-cell  monolayers pre- 
pared and drug-treated on round (2.2  cm in diameter) glass  coverslips.  Cells 
were fixed  with 2%  glutaraldehyde, critical  point-dried, and coated with gold 
as described previously (4). Photographs were taken on a JEOL 70T scanning 
electron microscope (JEOL USA, Electron Optics Div., Peabody, MA) operated 
at 25 kV. 
Transmission electron microscopy was carried out with monolayer cultures 
of L cells  prepared  in  glass  petri dishes of  l0  cm diam.  After experimental 
operations (such as virus infection and drug treatment) were complete, cells 
were fixed  immediately for  l0 min at room temperature in  PBS (Dulbecco's 
phosphate-buffered saline) containing 2%  glutaraldehyde  and  then  removed 
from the dish by scraping. Thereafter, cells were centrifuged (at  1,000 g for  l 
rain)  into  a  hard  pellet,  fixed  overnight  at  4*  in  2%  glutaraldehyde-PBS, 
postfixed in  1% OsO4-PBS  for 1-2 h at room temperature and stained en bloc 
for  l  h with  1% uranyl acetate.  Samples were then dehydrated, embedded in 
plastic (Poly/Bed 812: Polysciences,  Inc., Warrington, PA), sectioned, examined 
in a JEOL 100cx electron microscope, and photographed at a magnification of 
3,300. 
Indirect  Immunofluorescence:  Indirect immunofluorescence ex- 
periments to localize the VSV G protein and the influenza hemagglutinin were 
performed with cells grown and infected on 1.8 x  1.8-cm glass coverslips. Cells 
were fixed  for 15  min at room temperature in 3%  paraformaldehyde (freshly 
prepared) in  PBS.  They were then  washed thoroughly in  PBS  and  exposed 
sequentially  to  primary (mouse monoclonal) antibody  and  to  20-50  ug/ml 
affinity-purified,  fluorescein  isothiocyanate-labeled,  goat  anti-mouse  lgG 
(Sigma Chemical Co.).  Both incubations were for 60 min at room temperature. 
After the secondary antibody treatment,  cells  were washed in  PBS,  mounted 
(inverted) on microscope slides  in 90% glycerol/10% PBS, and photographed 
on Kodak Tri-X film (Eastman Kodak Co., Rochester, NY) in a Leitz Ortholux 
epifluorescence microscope (x63  oil  objective).  Primary antibodies were the 
following:  VSV  G  protein,  0.5-1.0  ug/ml antibody  (purified  by protein  A- 
Sepharose chromatography [9]) from anti-G hybridoma clone No.  18 (lgG2a: 
a gift of Dr. W. Volk [29]); influenza WSN hemagglutinin, supernatants (diluted 
1:20 in PBS containing 1.0% bovine serum albumin) from antihemagglutinin 
FIGURE  1  Appearance and movement of blebs on the surface of CB-treated L cells. Monolayer cells were exposed to medium 
containing 10/~g/ml CB and phase-contrast photographs were taken at the indicated times (in minutes) thereafter. The arrows 
identify blebs whose movement can be followed in successive panels. 
358  THE Journal OF CELL BIOLOGY  .  VOLUME 100, 1985 FIGURE  2  Scanning electron microscope photographs of a control L cell (top) and a similar cell that had been treated with 10 
~g/ml CB for 1 h at 37°C (bottom). Bleb clusters are clearly visible in the bottom panel. 
i 
O  u  g  m  80%' 
o  o 
~  0  0 
s09 
0  0 
0 
m  20q  L~ 
1.0  3.0  10.0 
Cytochalasin  B  Concentration  (pg/ml) 
FIGURE  3  Dependence of bleb cluster formation on CB concen- 
tration. Monolayer cultures of L cells were treated for 1 h at 37°C 
hybridoma clones AI3-18RI (IgG2a) and C5-1RI (IgG2b)  obtained  from Dr. 
W. Gerhard (Wistar Institute). None of the three primary antibodies  gave 
significant  staining  with uninfected  cells. 
RESULTS 
Treatment of L  cells with CB produced a  prompt effect on 
cell surface morphology. In the first  1-3 min after exposure 
to  l0  ~g/ml  CB,  substrate-attached  cells  contracted,  their 
microvilli were reabsorbed, and blebs appeared on the cell 
with medium containing CB at the indicated concentration. Cells 
were then viewed in the phase-contrast microscope and scored for 
the  presence of bleb clusters.  Each point  shown  represents  the 
result obtained from counting at least 50 cells. 
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erally to form clusters  at cell extremities  as shown in Figs.  l 
and 2.  80%  or more of the cells acquired bleb clusters,  and 
the clusters were stable at cell extremities  for 12 h or more in 
the  presence  of drug.  Nonadherent  (suspension)  cells  re- 
sponded similarly except that blebs aggregated to form a single 
large cluster (l,  15) instead of two or more smaller ones as 
was observed in monolayer cells. Infection with VSV or with 
influenza virus did not alter the overall morphologic response 
to CB. Blebs formed normally and migrated into clusters  at 
cell extremities  in infected cells as they did in uninfected ones. 
The maximum effect of CB on cell morphology was observed 
at doses  of ~6 ~g/ml or greater as shown in Fig.  3.  Lower 
doses produced a diminished response in a smaller proportion 
of cells. All morphologic effects of CB were reversible within 
90 rain at 37* when CB was removed from the cell growth 
medium. 
The effect  of CB on the cell surface  distribution  of viral 
glycoproteins was examined by infecting monolayer cells with 
VSV or with influenza virus for 6-10 h and then adding CB 
to the medium. Cells were  fixed at various times thereafter 
and the surface distribution of viral glycoproteins was probed 
FIGURE  4  Indirect immunofluorescent localization of the VSV G protein (a-d) and the influenza virus HA (e and f) in control and 
in CB-treated cells, a-d show the results obtained when L cells were infected with VSV for 6 h and fixed immediately (a) or after 
1 min (b), 15 min (c), or 60 min (d) of incubation in medium containing 10 pg/ml CB. e and fshow comparable results obtained 
with  cells  infected  with  influenza  virus  for  8  h  and  fixed  immediately (e) or after  60  rain  of  incubation  (f)  in  10  pg/ml  CB. 
Immunofluorescent staining for the VSV G  protein and the influenza HA was carried out as described in Materials and Methods. 
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that in untreated cells the VSV G protein was found in small 
speckles or patches more or less  uniformly distributed over 
the entire cell surface as shown in Fig. 4a. CB treatment had 
a significant effect on this distribution. As blebs were forming 
during the first 1-3 min of treatment, the speckled pattern of 
stain was lost and G protein accumulated in the blebs, partic- 
ularly at the base or "collar" of each bleb (Fig. 4 b). G protein 
FIGURE  5  Electron microscopic localization of VSV maturing from the surface of control (a) and CB-treated (b and c) L cells. Cells 
were infected with VSV tor 6 h and fixed immediately (a) or after 60 rain (b and c) of incubation in medium containing 10 ~g/ml 
CB. Arrows indicate the sites of VSV budding in CB-treated ceils. 
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to form clusters at cell extremities  as shown in Fig. 4c. When 
mature clusters  had formed (after  45-60 rain),  therefore,  all 
or  most  of the  G  protein  was  found  concentrated  in  the 
regions of clusters  as shown in Fig. 4d. This polarized distri- 
bution, which was observed in >_70% of the cells, did  not 
change significantly during an additional 3-4 h of incubation 
in the presence of CB. The behavior of the VSV G  protein 
was quite similar to that observed for the infuenza hemagglu- 
tinin (HA). HA was found in a speckled  distribution on the 
surface of untreated cells and polarized in the regions of bleb 
clusters in treated ones as shown in Fig. 4, e and f  Both the 
VSV G protein and the influenza HA reverted to the speckled 
distribution characteristic  of drug-free cells when treated cells 
were returned to normal growth medium for 90 rain or more 
at 37"C. 
Transmission electron microscopy was carded out to iden- 
tify the sites of virus maturation in CB-treated cells. Mono- 
layer L-cefl cultures were infected with VSV or with influenza 
virus for 6-10 h, treated for 60 min with  10 ug/ml CB, fixed, 
and  then  processed  for  electron  microscopy.  The  results 
showed that virus particles  in the process of maturing at this 
time were  located preferentially  in  the regions  of clustered 
blebs as shown in Figs. 5 and 6. It was very rare to see virus 
particles  budding  from  other areas  of the  cell  membrane. 
Most budding was observed not in the blebs or zeiotic knobs 
themselves,  but rather in the regions of membrane just prox- 
imal to the cell at the base of the blebs. This phenomenon is 
clearly illustrated  in Fig. 5, b and c. In contrast to the situation 
with CB-treated cells, in untreated cells, VSV was found to 
bud uniformly from all areas of the cell membrane (Fig. 5 a). 
Influenza virus matured predominantly from the upper (non- 
adherent) surface in untreated monolayer cells, but budding 
occurred  from  all  areas  of the  membrane  (Fig.  6a),  not 
specifically  from extreme  regions as  was  observed  in  CB- 
treated cells. 
Like the polarized distribution of the VSV G  protein and 
the  influenza  HA,  polarized  budding  of both  viruses  was 
found to be reversed  when CB was  removed from the cell 
growth medium. A uniform pattern of budding was observed 
in  CB-treated ceils  that  had been  incubated for 60  min  or 
more in the absence of drug. 
DISCUSSION 
The results described  above show a clear correlation between 
the  sites  of viral  maturation  and  the  location of envelope 
glycoproteins,  l~oth were  found  at  cell  extremities  in  CB- 
treated cells, but uniformly distributed on the membranes of 
untreated cells and of treated cells from which the drug had 
been removed. Our results raise the possibility  that envelope 
glycoproteins may be functionally involved in selecting  the 
region of membrane to be employed in viral budding. Bud- 
ding could, for instance,  be more rapid or more efficient from 
membrane sites  containing specific  envelope glycoproteins. 
This  conclusion  is  supported  by  studies  of virus-infected 
MDCK cells (24,  25).  When adherent  MDCK ceils are in- 
fected with VSV, the G  protein is found to be concentrated 
in the basolateral  portion of the membrane from which nearly 
all vesicular  stomatitis virions mature. Conversely, influenza 
FIGURE  6  Electron microscopic localization of influenza virus maturing from the surface of control (a) and CB-treated (b) L cells, 
Cells were infected with infuenza virus for 8  h and fixed immediately (a) or after 60 rain of incubation (b) in medium containing 
10/~g/ml C8, Arrows indicate the sites of virus budding. 
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membrane  where  their  envelope  glycoproteins  are  concen- 
trated  (25).  Neither  the  MDCK  experiments  nor  the  CB 
studies described here exclude the possibility that factors other 
than  envelope  glycoproteins  may  be  involved  in  specifying 
the  membrane  sites  of virus  budding  (24).  Both,  however, 
show a clear correlation between maturation and the location 
of viral glycoproteins. 
CB treatment of infected cells was crucial to the experimen- 
tal  strategy  employed  here.  CB  treatment  caused  both  the 
VSV G  protein and the influenza HA to be concentrated at 
cell extremities  in the regions of clustered blebs.  In contrast, 
in untreated cells bothglycoproteins were found in a speckled 
distribution more or less uniformly over the cell surface. The 
speckled distribution  appeared  to be due to a  concentration 
of viral  glycoproteins  on cellular  microvilli  as suggested  by 
Rodriguez-Boulan  and Pendergast  (25).  The CB-induced  re- 
striction of viral glycoproteins to cell extremities was reversi- 
ble when CB was removed from the cell growth medium, and 
CB  did  not  appear  to  decrease  the  overall  yield  of  virus 
particles maturing from the cell surface (7,  13,  18). CB treat- 
ment had a similar reversible effect on the distribution of two 
cellular glycoproteins, H-2 antigen and glyocprotein o (5), on 
the surface of uninfected  L-929  cells (N.  Salomonsky and J. 
Brown, unpublished  observations).  It is clear, therefore, that 
the effect of CB on the distribution cell surface glycoproteins 
was not limited to an effect on viral glycoproteins (27, 28). 
For both  the  VSV  G  protein  and the  influenza  HA,  CB 
appeared to produce a restricted glycoprotein distribution by 
relocalization of existing glycoprotein  molecules rather than 
by glycoprotein  loss followed by selective  insertion of newly 
synthesized material at cell extremities. There was no evidence 
of large-scale glycoprotein loss when infected cells were treated 
with CB and then examined by indirect immunofluorescence 
for the  presence  of virus-specific  surface  glycoproteins.  In- 
stead, existing  viral glycoproteins  appeared  to migrate in an 
orderly way to cell extremities  as shown in Fig.  4.  Internali- 
zation of viral  glycoproteins  followed  by  reinsertion  at  cell 
extremities also seems unlikely for the same reason. 
It is not at all clear at the molecular level how CB treatment 
can cause the striking glycoprotein relocalization observed in 
L-929 and other cell types (27, 28). Relocalization is unlikely 
to be caused  by a  direct  interaction  of CB  with  cell surface 
glycoproteins.  There  is  (to  our knowledge)  no evidence  for 
such a direct interaction. Instead, the effects of CB on surface 
glycoprotein distribution are more probably an indirect con- 
sequence of its effects on microfilaments.  These effects, such 
as drug binding and blockage of filament growth, have been 
clearly described  at the molecular level  in  studies involving 
the use of purified  F-actin (10,  19).  It is not clear, however, 
how the direct cytochalasin-actin  interactions observed with 
purified  components  may  account  for  the  complex  set  of 
effects, including effects on cytoplasmic microfilament distri- 
bution  (16,  23)  and  on  surface  glycoprotein  localization, 
produced by treatment of cultured cells with cytochalasin.  It 
is clear, on the other hand, that CB treatment can be employed 
effectively  to produce a  highly  polarized distribution  of cell 
surface glycoproteins (27, 28) as described above. 
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